Ohio based Bedford Laboratories, informed that the company has further diversified their product offerings with the addition of pre-filled syringes. FDA approval has been granted and Sumaptriptan Succinate injection, 6mg (base) / 0.5 mL pre-filled syringes are now available. This is a very important product addition to their expanding portfolio of products.
Sumaptriptan Succinate Injection is indicated for the acute treatment of migraine attacks with or without aura, and the acute treatment of cluster headache episodes.
Full article click here
No comments:
Post a Comment